Article Details
Retrieved on: 2021-03-22 19:36:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Furthermore, combination treatment of IMiDs and myeloma-targeting monoclonal antibodies eg. daratumumab (anti-CD38) and elotuzumab ...
Article found on: www.docwirenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here